DiaMedica Therapeutics (DMAC) Receivables - Net (2017 - 2026)
DiaMedica Therapeutics (DMAC) recorded Receivables - Net of $244,000 in Q2 2026, up 51.6% from $161,000 a year earlier but down 18.9% from the prior quarter.
Powered by 
Analysis
DiaMedica Therapeutics (DMAC) Receivables - Net (2017 - 2026) Analysis & Trends
At the end of FY2025, DiaMedica Therapeutics reported Receivables - Net of $258,000, up 9.3% from FY2024.
- Annual Receivables - Net has a five-year compound annual growth rate of -5.4% (FY2020 to FY2025).
- Across earlier years, Receivables - Net came in at $236,000 in FY2024 (-36.0%), $369,000 in FY2023 (+350.0%), $82,000 in FY2022 (-36.9%) and $130,000 in FY2021 (-61.8%).
- Quarterly Receivables - Net has ranged from $57,000 in Q1 2023 to $399,000 in Q1 2024 over the past five years.
- On a year-over-year basis, Receivables - Net has increased for three consecutive quarters, with an average decline of 8.6% over the last eight quarters.
- Peak year-over-year performance for Receivables - Net in the last five years was growth of 600.0% in Q1 2024, against a decline of 69.0% in Q3 2021 at the low end.
- Per Business Quant, the preceding three quarters came in at $301,000 (Q1 2026), $258,000 (Q4 2025) and $260,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | DiaMedica Therapeutics | 521.46 Mn | 311.42 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 244,000.00 |
| Mar 31, 2026 | 301,000.00 |
| Dec 31, 2025 | 258,000.00 |
| Sep 30, 2025 | 260,000.00 |
| Jun 30, 2025 | 161,000.00 |
| Mar 31, 2025 | 253,000.00 |
| Dec 31, 2024 | 236,000.00 |
| Sep 30, 2024 | 290,000.00 |
| Jun 30, 2024 | 391,000.00 |
| Mar 31, 2024 | 399,000.00 |
| Dec 31, 2023 | 369,000.00 |
| Sep 30, 2023 | 310,000.00 |
| Jun 30, 2023 | 188,000.00 |
| Mar 31, 2023 | 57,000.00 |
| Dec 31, 2022 | 82,000.00 |
| Sep 30, 2022 | 75,000.00 |
| Jun 30, 2022 | 88,000.00 |
| Mar 31, 2022 | 168,000.00 |
| Dec 31, 2021 | 130,000.00 |
| Sep 30, 2021 | 104,000.00 |
API Access
DiaMedica Therapeutics Receivables - Net API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-net&ticker=DMAC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-net", "ticker": "DMAC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-net&ticker=DMAC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();